CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Shaanxi Panlong Phrmctcl Gp Ld By Shr Ld is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Shaanxi Panlong Phrmctcl Gp Ld By Shr Ld
No. 2801
Baliu 2nd Road, Baqiao District
Phone: +86 2983338888p:+86 2983338888 XI'AN, SXI  710025  China Ticker: 002864002864
Business Summary
Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd is a China-based company primarily engaged in the standardized cultivation of medicinal materials, pharmaceutical production, research and development, sales, and pharmaceutical logistics. The Company's main products include Panlong Qipian, Panlong Qi Yao Jiu, Jin Yin Li Dan Capsules, Kebireti Tablets, Compound Gossypol Acetate Tablets, Gossypol Acetate API, functional health food Gujiaoguizhen Tablets, health care product Panlong Qi Tie and others. The Company's products cover categories such as rheumatism and bone injuries, cardiovascular and cerebrovascular diseases, digestion, tonification, clearing heat and detoxification, pediatrics, gynecology, and liver and gallbladder diseases. The Company mainly operates its businesses in the domestic market.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
9/30/202512/31/2024Yes----

Industries
SIC Code Description
2834 Pharmaceutical preparations
2833 Medicinal chemicals and botanical products
5122 Drugs, drug proprietaries, and druggists' sundries
8731 Commercial physical and biological research

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board XiaolinXie 57 1/29/2024 6/16/2013
Acting President, Vice President, Director DezhuZhang 49 8/15/2024 6/16/2013
Chief Financial Officer FengmingZhu 54
8 additional Officers and Directors records available in full report.

Business Names
Business Name
002864
Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd.

General Information
Number of Employees: 933 (As of 12/31/2024)
Outstanding Shares: 106,280,960 (As of 9/30/2025)
Shareholders: 28,220
Stock Exchange: SHE
Fax Number: +86 2983592658


Copyright © 2025 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Sunday, December 7, 2025